A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

Clinical trial NCT05198804 · COMPLETED

Trial details

NCT number: NCT05198804
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Platinum-resistant Ovarian Cancer Primary Peritoneal Carcinoma Fallopian Tube Cancer

Start date: 2022-01-27
Primary completion: 2025-10-15
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.